How much is a share of AQB stock?
Find the latest AquaBounty Technologies, Inc. (AQB) stock quote, history, news and other vital information to help you with your stock trading and investing.
Is Wall Street buying AquaBounty Technologies (AQB) stock?
Mar 18, 2022 · AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AQB shares have decreased by 8.6% and is now trading at $1.69. View which stocks have been most impacted by COVID-19.
What is AQB salmon?
Apr 18, 2022 · AQB AquaBounty Technologies Inc — Stock Price and Discussion | Stocktwits. AquaBounty Technologies Inc NASDAQ Updated Apr 18, 2022 10:06 PM. AQB 1.60 0.09 (5.33%) Post-Market 0.06 (3.75%) 8,212. Key Data. 52wk Low 1.32. 52wk High 6.58. Mkt Cap 120.89m.
What is the target price for Lake Street Capital (AQB) stock?
Apr 19, 2022 · About AQB AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, …
Is Aqb a good stock to buy?
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity.
Is Aqb a dividend stock?
AQUABOUNTY TECHNOLOGIES (NASDAQ: AQB) does not pay a dividend.
Why did AquaBounty stock drop?
Shares of AquaBounty Technologies ( AQB -2.87% ) fell on Wednesday, following a bearish technical analysis shared by well-known TV personality Jim Cramer. As of noon EDT, the stock was down 16%.Mar 24, 2021
Is AquaBounty Technologies a buy right now?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are curr...
How has AquaBounty Technologies' stock price been impacted by COVID-19?
AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organiz...
When is AquaBounty Technologies' next earnings date?
AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, May 3rd 2022. View our earnings forecast for...
How were AquaBounty Technologies' earnings last quarter?
AquaBounty Technologies, Inc. (NASDAQ:AQB) issued its quarterly earnings results on Thursday, March, 10th. The company reported ($0.09) EPS for the...
What price target have analysts set for AQB?
4 Wall Street analysts have issued 12-month price objectives for AquaBounty Technologies' shares. Their forecasts range from $4.50 to $15.00. On av...
Who are AquaBounty Technologies' key executives?
AquaBounty Technologies' management team includes the following people: Sylvia A. Wulf , President, Chief Executive Officer & Director Alejandro...
Who are some of AquaBounty Technologies' key competitors?
Some companies that are related to AquaBounty Technologies include Dyne Therapeutics (DYN) , Chimerix (CMRX) , Provention Bio (PRVB) , Joint (J...
What other stocks do shareholders of AquaBounty Technologies own?
Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Ther...
What is AquaBounty Technologies' stock symbol?
AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."
Is AquaBounty Technologies a buy right now?
What stocks does MarketBeat like better than AquaBounty Technologies?
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock.
When is AquaBounty Technologies' next earnings date?
Wall Street analysts have given AquaBounty Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AquaBounty Technologies wasn't one of them.
How were AquaBounty Technologies' earnings last quarter?
AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 2nd 2021.#N#View our earnings forecast for AquaBounty Technologies.
How has AquaBounty Technologies' stock been impacted by Coronavirus (COVID-19)?
AquaBounty Technologies, Inc. (NASDAQ:AQB) announced its earnings results on Tuesday, August, 3rd. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.12. The company earned $0.23 million during the quarter, compared to analyst estimates of $0.53 million.
What price target have analysts set for AQB?
AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AQB shares have increased by 136.8% and is now trading at $4.38.#N#View which stocks have been most impacted by COVID-19.
Who are some of AquaBounty Technologies' key competitors?
4 Wall Street analysts have issued twelve-month target prices for AquaBounty Technologies' stock. Their forecasts range from $5.00 to $15.00. On average, they expect AquaBounty Technologies' share price to reach $9.00 in the next year.
About AQB
Some companies that are related to AquaBounty Technologies include bluebird bio (BLUE), Avid Bioservices (CDMO), Cullinan Oncology (CGEM), Concordia International (CXR), Oxford Biomedica (OXB), Antibe Therapeutics (ATBPD), Cyclo Therapeutics (CTDH), Heron Therapeutics (HRTX), ImmunoGen (IMGN), (BTCA) (BTCA), MannKind (MNKD), Janux Therapeutics (JANX), Coherus BioSciences (CHRS), Sundial Growers (SNDL) and GH Research (GHRS).#N#View all of AQB's competitors..
Financial Performance
AquaBounty Technologies, Inc., a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.
Analyst Forecast
In 2020, AQB's revenue was $127,663, a decrease of -31.64% compared to the previous year's $186,738. Losses were -$16.40 million, 24.0% more than in 2019.
News
According to 3 analysts, the average rating for AQB stock is "Strong Buy." The 12-month stock price forecast is 11.00, which is an increase of 137.07% from the latest price.
Recently Viewed Tickers
Catherine Wood (Trades, Portfolio) disclosed earlier this week her firm, ARK Investment Management, reduced two of its positions in July.
AquaBounty Technologies Inc
Visit a quote page and your recently viewed tickers will be displayed here.
Component Grades
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. It includes farming of aquatic organisms such as fish, shellfish, crustaceans, and aquatic plants. The firm focuses on salmon product, a bioengineered Atlantic salmon that can grow to market size faster than conventional farmed Atlantic salmon.
AQB POWR Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
AQB Stock Summary
Growth is the dimension where AQB ranks best; there it ranks ahead of 57.71% of US stocks.
AQB Valuation Summary
With a price/sales ratio of 742.87, AquaBounty Technologies Inc has a higher such ratio than 98.97% of stocks in our set.
AQB Stock Chart
In comparison to the median Consumer Defensive stock, AQB's price/earnings ratio is 178.14% lower, now standing at -16.8.
Profile
AquaBounty Technologies, Inc., a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts
Signals & Forecast
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. It includes farming of aquatic organisms such as fish, shellfish, crustaceans, and aquatic plants. The firm focuses on salmon product, a bioengineered Atlantic salmon that can grow to market size faster than conventional farmed Atlantic salmon.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Thursday, August 19, 2021, and so far it has risen 5.26%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD).
Is AquaBounty Technologies Inc stock A Buy?
AquaBounty Technologies Inc finds support from accumulated volume at $4.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
